AtomVie’s expansion will support 70 jobs and reinforce Ontario’s position as a global leader in the production of life-saving radiopharmaceuticals
HAMILTON — The Ontario government is welcoming an investment of over $138 million from AtomVie Global Radiopharma Inc., a homegrown, leading manufacturer of radiopharmaceuticals, to expand its facility in Hamilton. The investment will sustain 131 existing jobs and create 70 new, high-paying jobs, while expanding domestic manufacturing capacity to help bring life-saving cancer treatments to patients in Canada and around the world.
“AtomVie’s investment is terrific news for Hamilton workers and strengthens Ontario’s position as a global leader in the production and delivery of radiopharmaceuticals,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “With global demand for targeted therapies set to ramp up in the years ahead, AtomVie’s expanded Hamilton facility adds a critical link to our province’s life sciences supply chain and ensures that the production and research of life-saving medical treatments happens right here in Ontario.”
AtomVie’s expansion will increase production capacity to support both clinical trials and commercial manufacturing of innovative radiopharmaceuticals, solidifying the province’s competitive advantage in the critical life sciences field. These technologies are increasingly important in oncology, enabling targeted therapies that destroy cancer cells more precisely while avoiding healthy cells, leading to fewer side effects than traditional oncology treatments. In support of this investment, Ontario is providing up to $5 million in funding through the Invest Ontario Fund.
“We are proud to make this significant investment in Ontario’s life sciences ecosystem,” said Bruno Paquin, Chief Executive Officer, AtomVie. “With more than $138 million committed by AtomVie, this facility will expand access to high-quality radiopharmaceutical manufacturing and ensure that innovative therapies can reach patients who need them. Ontario’s strong nuclear medicine infrastructure and growing radiopharmaceutical community make it the ideal home for this next phase of growth.”
With U.S. tariffs impacting workers and businesses across key sectors, the Ontario government is protecting the province by lowering taxes, reducing red tape, and making strategic investments that will build Ontario into the most resilient, self-reliant and competitive economy in the G7. Since 2018, Ontario has attracted a historic $113 billion in foreign direct investments and created one million new jobs. AtomVie’s investment is the third major project announced by the government this week, totalling $400.8 million and up to 435 Ontario jobs.
Quick Facts
- The 2025 Ontario Economic Outlook and Fiscal Review continues to protect Ontario and supports a more competitive, resilient and self-reliant economy by cutting red tape, investing in infrastructure, supporting workers, improving services and making life more affordable.
- Ontario is strengthening its life sciences sector by expanding domestic manufacturing capacity, reinforcing its global leadership in medical isotopes, and advancing the goals outlined in its Life Sciences Strategy, Taking Life Sciences to the Next Level.
- Ontario has attracted over $6 billion in life sciences investments since 2018.
- Ontario is home to almost 2,000 life sciences firms that export over $11.8 billion annually and employ more than 74,000 people.
- Founded as a spin-out of McMaster University’s Centre for Probe Development and Commercialization, AtomVie is the only Contract Development and Manufacturing Organization of this scale in Canada specializing in radiopharmaceuticals.
- Every year, more than 86,000 STEM students graduate from post-secondary programs across the province, producing one of the most highly skilled workforces in the world.
- Since its inception, Invest Ontario has announced over $11.4 billion in investments, resulting in the creation of more than 10,500 jobs in the province.
This press release was originally published by Economic Development, Job Creation and Trade and published on December 3, 2025. Read the full release here.